Dr. Joan A. O’Keefe’s lab at Rush University are researching the effect of treadmill training with or without a combined thinking task in people with FXTAS.
Participation
Who can participate?
The study is looking for FXTAS patients of any age. You may be able to participate in this study if you are able to stand unassisted and walk for at least 2 minutes.
You will NOT be able to participate in the trial if you have:
- A history of traumatic brain injury, stroke, or multiple sclerosis with changes on CT/MRI.
- Significant cardiopulmonary or cardiovascular disease, dementia, or unstable psychiatric disorders including major depression or schizophrenia.
What will happen in the study?
You will be asked to:
- Walk on a treadmill at your comfortable speed for 20 to 45 minutes or walk on a treadmill while doing a mental exercise for the same duration, 3 times per week for 6 weeks. You will be supported by a safety harness while on the treadmill and carefully monitored throughout.
- Wear sensors around your wrists, ankles, chest, and waist during the balance and walking tests; these are worn outside of your regular clothing.
- Have a short neurological examination and neuropsychological tests.
- Answer questionnaires about your balance confidence and any symptoms of anxiety, sleep, and depression.
- Have blood drawn for measuring the levels of a growth factor in your blood.
- Have an MRI.
- Go through the assessment tests (#2 through #6 above) before the trial and then immediately after, 1-month, and 6-months following the trial.
The time it takes to complete the above tests is 1.5 to 2 hours.
Will you/your child be paid to complete this survey?
Participants will NOT be monetarily compensated for participation in this study.
Study Locations
The testing will be performed in two locations in Chicago:
Rush University Armour Academic Center
600 South Paulina
Rush University Hospital
Kellogg Building Room 235K
1625 West Harrison
For more information
- Deborah Bang at (917) 708-0554 or deborah_bang@rush.edu
- Joan Ann O’Keefe, PT, Ph.D., at (312) 563-3940 or joan_a_okeefe@rush.edu
Our Most Recent Opportunities
IMPACT-FXS: Investigating Multiple Pathways And Combined Treatments for FXS
Healx is conducting a Phase 2, placebo-controlled study in adolescent and adult males with fragile X syndrome (FXS). The purpose of this study is to confirm whether Healx's drug candidates are safe and work as intended to reduce symptoms of FXS.
Survey: Developing a Gold Standard for Tracking Adult Functional Outcomes in Developmental Disabilities (AFS Study)
University of Pittsburgh is conducting this research to develop the Adult Functioning Scale (AFS), a new survey being designed to capture outcomes in the areas of social functioning, employment, independence, and satisfaction for individuals with various developmental disorders.
Study: Aging in Toolbox
Researchers around the country are conducting a study to better understand cognitive profiles in adults with intellectual disability. This study is an extension of the ongoing Toolbox Study, which is aimed to optimize cognitive assessment tools for children and young adults with intellectual disabilities.
Conference Research Opportunity: Validation of Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)
Rush University is conducting a research study to validate a rating scale created to assess the motor symptoms of people with FXTAS – the “Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)”
Study: Connection between Cognition and Genetic Factors in Adults with FXS
Drs. Craig Erickson and Lauren Schmitt at Cincinnati Children’s Hospital are conducting a series of research studies to learn about the brain and cognition and how they are connected with genetic factors related to FXS.
Study: UNC Brain Development Research Study of Infants with Fragile X Syndrome
UNC Chapel Hill is conducting a research study to learn about the early brain and behavioral development of infants with FXS to aid in the future development of better supports and treatments.